Groupe la Francaise’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1M Buy
63,537
+12,994
+26% +$2.7M 0.18% 95
2026
Q1
$10.7M Buy
50,543
+50,477
+76,480% +$10.9M 0.15% 108
2025
Q4
$13.6K Sell
66
-13,876
-100% -$2.61M ﹤0.01% 419
2025
Q3
$2.19M Buy
13,942
+13,557
+3,521% +$2.09M 0.03% 237
2025
Q2
$64.6K Buy
385
+29
+8% +$4.3K ﹤0.01% 402
2025
Q1
$48.6K Sell
356
-398
-53% -$50.7K ﹤0.01% 407
2024
Q4
$89.3K Buy
+754
New +$88K ﹤0.01% 293

Other funds holding CAH

Groupe la Francaise's CAH Position: Q2 2026 in Review

Groupe la Francaise increased its Cardinal Health (CAH) stake by 26% in Q2 2026, buying an estimated $2.7M and bringing the position to 63,537 shares worth $15.1M. The position accounts for 0.18% of the portfolio, ranked #95.

Groupe la Francaise first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Groupe la Francaise held 63,537 shares of Cardinal Health worth $15.1M as of Q2 2026.
  • Groupe la Francaise bought 12,994 Cardinal Health shares in Q2 2026, an estimated $2.7M.
  • Cardinal Health made up 0.18% of Groupe la Francaise's portfolio in Q2 2026, its #95 holding.
  • Groupe la Francaise first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.